Capecitabine-induced pancreatitis

Journal of Oncology Pharmacy Practice

Volumn 16, Issue 2, 2010, Pages 133-134

  Yucel, Hanifi ^a   Warmerdam, Laurence V ^a  

^a CATHARINA HOSPITAL   (Netherlands)

Author keywords

Acute pancreatitis; Capecitabine; Rechallenge

Indexed keywords

AMYLASE; CAPECITABINE; OXALIPLATIN;

ABDOMINAL PAIN; ABDOMINAL TENDERNESS; ACUTE PANCREATITIS; ADULT; AMYLASE BLOOD LEVEL; ARTICLE; BED REST; CANCER ADJUVANT THERAPY; CANCER SURGERY; CASE REPORT; COLON RESECTION; DRUG RECHALLENGE; DRUG WITHDRAWAL; FEMALE; HUMAN; IDIOPATHIC DISEASE; MULTIPLE CYCLE TREATMENT; PERITONITIS; PRIORITY JOURNAL; RECURRENT DISEASE; REHYDRATION; SIGMOID CARCINOMA; THERAPY EFFECT; TREATMENT DURATION; URINE LEVEL;

ADULT; DEOXYCYTIDINE; FEMALE; FLUOROURACIL; HUMANS; PANCREATITIS; SIGMOID NEOPLASMS;

EID: 77952780785     PISSN: 10781552     EISSN: None     Source Type: Journal    
DOI: 10.1177/1078155209344650     Document Type: Article

References (3)

1. Roche Pharmaceuticals. Xeloda (capecitabine) package insert. Nutley, NJ, 2001.
2. Walko CM, Lindley C. Capecitabine: a review. Clin ther 2005 ; 27 (1). 23-44.
3. Jones KL, Valero V. Capecitabine-induced pancreatitis. Pharmacotherapy 2003 ; 23 (8). 1076-1078.